Link between cognitive impairment and worse prognosis in heart failure patients

August 26, 2020

Heart failure is an endemic disease affecting 250 000 Swedes. Despite new treatments such as modern medicines and defibrillators, the mortality rate is still high and the prognosis worse than for certain cancers. A new study from Lund University in Sweden now shows a link between cognitive impairment and an increased risk for rehospitalisation, or an early death, in heart failure patients.

Researchers at Skåne University Hospital and Lund University conducted the new study, published in the medical journal ESC Heart Failure. It is the first study in which cognitive impairment is linked to worse prognoses in a larger group of heart failure patients who have received care at Skåne University Hospital in Malmö.

Cognitive ability refers to, for example, memory, the ability to orient oneself in time and place, problem solving and the use of numbers and language.

"The patients were asked to complete three different cognitive tests within the framework for the study. The independent connection we could see was that patients who performed worse on the tests arewere at an increased risk of rehospitalisation and at an increased risk of death", says Martin Magnusson, consultant in cardiology at Skåne University Hospital and adjunct professor at Lund University.

The study looked at 281 patients of whom 80 demonstrated cognitive impairment in the tests. However, only four of them were previously aware that their cognitive ability was impaired.

"It could be that this patient group has a reduced ability to comply with evidence-based treatment recommendations - particularly if they are unaware of their cognitive impairment. However, this has not been studied", says Martin Magnusson.

Hannes Holm, resident physician in cardiology at Skåne University Hospital and post doc in Martin Magnusson's research group, emphasises that the study only shows a link between the results of the cognitive tests and the rehospitalisation and death of heart failure patients.

"As yet, we still do not know if it is the cognitive impairment that has this effect on the prognosis of heart failure patients, or if it is the heart failure itself that affects the cognition", says Hannes Holm.

It has also not been studied how heart failure patients would react to being screened for cognitive function and then receive cognitive support in their heart failure treatment.

"This is something we want to look at further. If our hypothesis is correct, it could mean that this patient group can be offered greater support in their cognitive ability, which in turn can be a simple and pragmatic way to save more lives", says Martin Magnusson.
-end-


Lund University

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.